Advanced search
Publication Cover
Future Microbiology Volume 4, 2009 - Issue 8
Submit an article Journal homepage
1,179
Views
0
CrossRef citations to date
0
Altmetric
Review

Clostridial Toxins

Michel R Popoffa Institut Pasteur, Bactéries Anaérobies et Toxines, 28 rue du Dr Roux, 75724 Paris cedex 15, France. Tel.: +33 145 688 307 Fax: +33 140 613 [email protected]
&
Philippe Bouvetb Institut Pasteur, Bactéries Anaérobies et Toxines, 28 rue du Dr Roux, 75724 Paris cedex 15, France. Tel.: +33 140 613 509 Fax: +33 140 613 [email protected]
Pages 1021-1064 | Published online: 13 Oct 2009

Bibliography

  • Brüggemann H , BäumerS, FrickeWF et al.: The genome sequence of Clostridium tetani, the causative agent of tetanus disease.Proc. Natl Acad. Sci. USA100 , 1316–1321 (2003).
  • Brüggemann H , GottschalkG: Insights in metabolism and toxin production from the complete genome sequence of Clostridium tetani.Anaerobe10 , 53–68 (2004).
  • Sebaihia M , PeckMW, MintonNP et al.: Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes.Genome Res.17 , 1082–1092 (2007).
  • Sebaihia M , WrenBW, MullanyP et al.: The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome.Nat. Genet.38 , 779–786 (2006).
  • Shimizu T , OhtaniK, HirakawaH et al.: Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater.Proc. Natl Acad. Sci. USA99 , 996–1001 (2002).
  • Stackebrandt E , HippeH: Taxonomy and systematics. In: Clostridia. Bahl H, Dürre P (Eds). Willey-VCH, Weinheim, Germany, 19–48 (2001).
  • Popoff MR , StilesBG: Clostridial toxins vs. other bacterial toxins. In: Handbook of Clostridia. Dürre P (Ed.). Taylor and Francis, FL, USA, 323–383 (2005).
  • Songer JG : Clostridial enteric diseases of domestic animals.Clin. Microbiol. Rev.9 , 216–234 (1996).
  • Geny B , PopoffMR: Bacterial protein toxins and lipids: pore formation or toxin entry into cells.Biol. Cell98 , 667–678 (2006).
  • Deguchi A , MiyamotoK, KuwaharaT et al.: Genetic characterization of type A enterotoxigenic Clostridium perfringens strains.PLoS One4 , e5598 (2009).
  • Katayama S , DupuyB, ColeST: Rapid expansion of the physical and genetic map of the chromosome of Clostridium perfringens CPN50.J. Bacteriol.177 , 5680–5685 (1995).
  • Tweten RK : Nucleotide sequence of the gene for perfringolysin O (θ toxin) from Clostridium perfringens: significant homology with the genes for streptolysin and pneumolysin.Infect. Immun.56 , 3235–3240 (1988).
  • Alouf J : Cholesterol binding toxins (Streptococcus, Bacillus, Clostridium, Listeria). In: Guidebook to Protein Toxins and their Use in Cell Biology. Rappuoli R, Montecucco C (Eds). Sambrook & Tooze Publications, Oxford, UK, 7–10 (1997).
  • Alouf JE : Molecular features of the cytolytic pore forming bacterial protein toxins.Folia Microbiol. (Praha)48 , 5–16 (2003).
  • Tweten RK : Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins.Infect. Immun.73 , 6199–6209 (2005).
  • Rossjohn J , FeilSC, McKinstryWJ, TwetenRK, ParkerMW: Structure of a cholesterol-binding thiol-activated cytolysin and a model of its membrane form.Cell89 , 685–692 (1997).
  • Soltani CE , HotzeEM, JohnsonAE, TwetenRK: Structural elements of the cholesterol-dependent cytolysins that are responsible for their cholesterol-sensitive membrane interactions.Proc. Natl Acad. Sci. USA104 , 20226–20231 (2007).
  • Soltani CE , HotzeEM, JohnsonAE, TwetenRK: Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin.J. Biol. Chem.282 , 15709–15716 (2007).
  • Sekino-Suzuki N , NakamuraM, MitsuiK, Ohno-IwashitaO: Contribution of individual tryptophan residues to the structure and activity of θ-toxin (pefringolysin O), a cholesterol-binding cytolysin.Eur. J. Biochem.241 , 941–947 (1996).
  • Waheed AA , ShimadaY, HeijnenHFG et al.: Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts).Proc. Natl Acad. Sci. USA98 , 4926–4931 (2001).
  • Shepard L , ShaturskyO, JohnsonA, TwetenR: The mechanism of pore assembly for a cholesterol-dependent cytolysin: formation of a large prepore complex precedes the insertion of the transmembrane β-hairpins.Biochemistry39 , 10284–10293 (2000).
  • Dang TX , HotzeEM, RouillerI, TwetenRK, Wilson-KubalekEM: Prepore to pore transition of a cholesterol-dependent cytolysin visualized by electron microscopy.J. Struct. Biol.150 , 100–108 (2005).
  • Ramachandran R , TwetenRK, JohnsonAE: Membrane-dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and intersubunit β-strand alignment.Nat. Struct. Mol. Biol.11 , 697–705 (2004).
  • Heuck AP , SavvaCG, HolzenburgA, JohnsonAE: Conformational changes that effect oligomerization and initiate pore formation are triggered throughout perfringolysin O upon binding to cholesterol.J. Biol. Chem.282 , 22629–22637 (2007).
  • Rossjohn J , PolekhinaG, FeilSC, MortonCJ, TwetenRK, ParkerMW: Structures of perfringolysin O suggest a pathway for activation of cholesterol-dependent cytolysins.J. Mol. Biol.367 , 1227–1236 (2007).
  • Ramachandran R , HeuckAP, TwetenRK, JohnsonAE: Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin.Nat. Struct. Biol.9 , 823–827 (2002).
  • Heuck AP , HotzeEM, TwetenRK, JohnsonAE: Mechanism of membrane insertion of a multimeric β-barrel protein: perfringolysin O creates a pore using ordered and coupled conformational changes.Mol. Cell6 , 1233–1242 (2000).
  • Heuck AP , TwetenRK, JohnsonAE: β-Barrel Pore-Forming Toxins: Intriguing Dimorphic Proteins.Biochemistry40 , 9065–9073 (2001).
  • Shatursky O , HeuckA, ShepardL et al.: The mechanism of membrane insertion of a cholesterol-dependent cytolysin: a novel paradigm for pore-forming toxins.Cell99 , 293–299 (1999).
  • Hotze EM , HeuckAP, CzajkowskyDM, ShaoZ, JohnsonAE, TwetenRK: Monomer–monomer interactions drive the prepore to pore conversion of a β-barrel-forming cholesterol-dependent cytolysin.J. Biol. Chem.277 , 11597–11605 (2002).
  • Czajkowsky DM , HotzeEM, ShaoZ, TwetenRK: Vertical collapse of a cytolysin prepore moves its transmembrane β-hairpins to the membrane.EMBO J.23 , 3206–3215 (2004).
  • Nelson LD , JohnsonAE, LondonE: How interaction of perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological low pH: insights into the origin of perfringolysin O-lipid raft interaction.J. Biol. Chem.283 , 4632–4642 (2008).
  • Stevens DL , TwetenRK, AwadMM, RoodJI, BryantAE: Clostridial gas gangrene: evidence that α and τ-toxin differentially modulate the immune response and induce acute tissue necrosis.J. Infect. Dis.176 , 189–195 (1997).
  • Bryant AE , BergstromR, ZimmermanGA et al.: Clostridium perfringens invasiveness is enhanced by effects of θ toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein.FEMS Immunol. Med. Microbiol.7 , 321–326 (1993).
  • Bryant AE , StevensDL: Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis on cultured human umbilical vein endothelial cells.Infect. Immun.64 , 358–362 (1996).
  • Awad MM , EllenorDM, BodRL, EmminsJJ, RoodJI: Synergistic effects of α-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene.Infect. Immun.69 , 7904–7910 (2001).
  • Stevens DL , BryantAE: The role of clostridial toxins in the pathogenesis of gas gangrene.Clin. Infect. Dis.35 , S93–S100 (2002).
  • Sayeed S , Fernandez-MiyakawaME, FisherDJ et al.: E-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model.Infect. Immun.73 , 7413–7421 (2005).
  • Fernandez Miyakawa ME , UzalFA: The early effects of Clostridium perfringens type D ε toxin in ligated intestinal loops of goats and sheep.Vet. Res. Commun.27 , 231–241 (2003).
  • Losada-Eaton DM , UzalFA, Fernandez Miyakawa ME: Clostridium perfringens ε toxin is absorbed from different intestinal segments of mice. Toxicon51 , 1207–1213 (2008).
  • Tamai E , IshidaT, MiyataS et al.: Accumulation of Clostridium perfringens ε-toxin in the mouse kidney and its possible biological significance.Infect. Immun.71 , 5371–5375 (2003).
  • Uzal FA , SongerJG: Diagnosis of Clostridium perfringens intestinal infections in sheep and goats.J. Vet. Diagn. Invest.20 , 253–265 (2008).
  • Nagahama M , SakuraiJ: Distribution of labeled Clostridium perfringens ε toxin in mice.Toxicon29 , 211–217 (1991).
  • Nagahama M , SakuraiJ: High-affinity binding of Clostridium perfringens ε-toxin to rat brain.Infect. Immun.60 , 1237–1240 (1992).
  • Finnie JW : Neurological disorders produced by Clostridium perfringens type D ε toxin.Anaerobe10 , 145–150 (2004).
  • Soler-Jover A , DorcaJ, PopoffMR et al.: Distribution of Clostridium perfringens ε toxin in the brains of acutely intoxicated mice and its effect upon glial cells.Toxicon50 , 530–540 (2007).
  • Dorca-Arevalo J , Soler-JoverA, GibertM, PopoffMR, Martin-SatueM, BlasiJ: Binding of ε-toxin from Clostridium perfringens in the nervous system.Vet. Microbiol.131 , 14–25 (2008).
  • Finnie JW : Pathogenesis of brain damage produced in sheep by Clostridium perfringens type D ε toxin: a review.Aust. Vet. J.81 , 219–221 (2003).
  • Miyamoto O , MinamiJ, ToyoshimaT et al.: Neurotoxicity of Clostridium perfringens ε-toxin for the rat hipocampus via glutamanergic system.Infect. Immun.66 , 2501–2508 (1998).
  • Hunter SE , ClarkeIN, KellyDC, TitballRW: Cloning and nucleotide sequencing of the Clostridium perfringens ε-toxin gene and its expression in Escherichia coli.Infect. Immun.60 , 102–110 (1992).
  • Minami J , KatayamaS, MatsushitaO, MatsushitaC, OkabeA: λ-toxin of Clostridium perfringens activates the precursor of ε-toxin by releasing its N- and C-terminal peptides.Microbiol. Immunol.41 , 527–535 (1997).
  • Cole A : Structural studies on ε toxin from Clostridium perfringens. In: Protein Toxins of the Genus Clostridium and Vaccination. Duchesnes C, Mainil J, Popoff MR, Titball R (Eds). Presses de la Faculté de Médecine Vétérinaire, Liège, Belgium, 95 (2003).
  • Sakurai J : Toxins of Clostridium perfringens.Rev. Med. Microbiol.6 , 175–185 (1995).
  • Oyston PCF , PayneDW, HavardHL, WilliamsonED, TitballRW: Production of a non-toxic site-directed mutant of Clostridium perfringens ε-toxin which induces protective immunity in mice.Microbiology144 , 333–341 (1998).
  • Heine K , PustS, EnzenmullerS, BarthH: ADP-ribosylation of actin by the Clostridium botulinum C2 toxin in mammalian cells results in delayed caspase-dependent apoptotic cell death.Infect. Immun.76 , 4600–4608 (2008).
  • Lindsay CD , HambrookJL, UpshallDG: Examination of toxicity of Clostridium perfringens ε-toxin in the MDCK cell line.Toxicol. In Vitro9 , 213–218 (1995).
  • Payne DW , WilliamsonED, HavardH, ModiN, BrownJ: Evaluation of a new cytotoxicity assay for Clostridium perfringens type D ε toxin.FEMS Microbiol. Lett.116 , 161–168 (1994).
  • Petit L , GibertM, GilletD, Laurent-WinterC, BoquetP, PopoffMR: Clostridium perfringens ε-toxin acts on MDCK cells by forming a large membrane complex.J. Bacteriol.179 , 6480–6487 (1997).
  • Shortt SJ , TitballRW, LindsayCD: An assessment of the in vitro toxicology of Clostridium perfringens type D ε-toxin in human and animal cells.Hum. Exp. Toxicol.19 , 108–116 (2000).
  • Miyata S , MatsushitaO, MinamiJ, KatayamaS, ShimamotoS, OkabeA: Cleavage of C-terminal peptide is essential for heptamerization of Clostridium perfringens ε-toxin in the synaptosomal membrane.J. Biol. Chem.276 , 13778–13783 (2001).
  • Miyata S , MinamiJ, TamaiE, MatsushitaO, ShimamotoS, OkabeA: Clostridium perfringens ε-toxin forms a heptameric pore within the detergent-insoluble microdomains of Madin–Darby canine kidney cells and rat synaptosomes.J. Biol. Chem.277 , 39463–39468 (2002).
  • Payne D , WilliamsonED, TitballRW: The Clostridium perfringens ε-toxin.Rev. Med. Microbiol.8 , S28–S30 (1997).
  • Chassin C , BensM, de Barry J et al.: Pore-forming ε toxin causes membrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells. Am. J. Physiol. Renal Physiol.293 , F927–F937 (2007).
  • Shimamoto S , TamaiE, MatsushitaO, MinamiJ, OkabeA, MiyataS: Changes in ganglioside content affect the binding of Clostridium perfringens ε-toxin to detergent-resistant membranes of Madin–Darby canine kidney cells.Microbiol. Immunol.49 , 245–253 (2005).
  • Nagahama M , HaraH, Fernandez-MiyakawaM, ItohayashiY, SakuraiJ: Oligomerization of Clostridium perfringens ε-toxin is dependent upon membrane fluidity in liposomes.Biochemistry45 , 296–302 (2006).
  • Petit L , MaierE, GibertM, PopoffMR, BenzR: Clostridium perfringens ε-toxin induces a rapid change in cell membrane permeability to ions and forms channels in artificial lipid bilayers.J. Biol. Chem.276 , 15736–15740 (2001).
  • Petit L , GibertM, GourchA, BensM, VandewalleA, PopoffMR: Clostridium perfringens ε toxin rapidly decreases membrane barrier permeability of polarized MDCK cells.Cell. Microbiol.5 , 155–164 (2003).
  • Buxton D : The use of an imunoperoxidase technique to investigate by light and electron microscopy the sites of binding of Clostridium welchii type D ε-toxin in mice.J. Med. Microbiol.11 , 289–292 (1978).
  • Finnie JW , BlumbergsPC, ManavisJ: Neuronal damage produced in rat brains by Clostridium perfringens type D ε-toxin.J. Comp. Path.120 , 415–420 (1999).
  • Zhu C , GhabrielMN, BlumbergsPC et al.: Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood brain barrier (BBB).Exp. Neurol.169 , 72–82 (2001).
  • Miyamoto O , SumitamiK, NakamuraT et al.: Clostridium perfringens ε toxin causes excessive release of glutamate in the mouse hippocampus.FEMS Microbiol. Lett.189 , 109–113 (2000).
  • Kennedy CL , KrejanyEO, YoungLF et al.: The α-toxin of Clostridium septicum is essential for virulence.Mol. Microbiol.57 , 1357–1366 (2005).
  • Melton JA , ParkerMW, RossjohnJ, BuckleyJT, TwetenRK: The identification and structure of the membrane-spanning domain of the Clostridium septicum α toxin.J. Biol. Chem.279 , 14315–14322 (2004).
  • Imagawa T , DohiY, HigashiY: Cloning, nucleotide sequence and expression of a hemolysin gene of Clostridium septicum.FEMS Microbiol. Lett.117 , 287–292 (1994).
  • Ballard J , CrabtreeJ, RoeBA, TwetenRK: The primary structure of Clostridium septicum α-toxin exhibits similarity with that of Aeromonas hydrophila aerolysin.Infect. Immun.63 , 340–344 (1995).
  • Ballard J , BryantA, StevensD, TwetenRK: Purification and characterization of the lethal toxin (α-toxin) of Clostridium septicum.Infect. Immun.60 , 784–790 (1992).
  • Melton-Witt JA , BentsenLM, TwetenRK: Identification of functional domains of Clostridium septicum α toxin.Biochemistry45 , 14347–14354 (2006).
  • Amimoto K , SasakiY, FukuyamaS, TamuraY: Genetic variation and cross-reactivity of Clostridium septicum α-toxin.Vet. Microbiol.114 , 51–59 (2006).
  • Gordon VM , BenzR, FujiiK, LepplaSH, TwetenRK: Clostridium septicum α-toxin is proteolytically activated by furin.Infect. Immun.65 , 4130–4134 (1997).
  • Ballard J , SokolovY, YuanWL, KaganBL, TwetenRK: Activation and mechanism of Clostridium septicum α toxin.Mol. Microbiol.10 , 627–634 (1993).
  • Gordon VM , NelsonKL, BuckleyJT et al.: Clostridium septicum α-toxin uses glycosylphosphatidylinositol-anchored protein receptors.J. Biol. Chem.274 , 27274–27280 (1999).
  • Hong Y , OhishiK, InoueN et al.: Requirement of N-glycan on GPI-anchored proteins for efficient binding of aerolysin but not Clostridium septicum α-toxin.EMBO J.21 , 5047–5056 (2002).
  • Hang‘ombe MB , MukamotoM, KohdaT, SugimotoN, KozakiS: Cytotoxicity of Clostridium septicum α-toxin: its oligomerization in detergent resistant membranes of mammalian cells.Microb. Pathog.37 , 279–286 (2004).
  • Sellman BR , TwetenRK: The propeptide of Clostridium septicum α toxin functions as an intramolecular chaperone and is a potent inhibitor of α toxin-dependent cytolysis.Mol. Microbiol.25 , 429–440 (1997).
  • Sellman BR , KaganBL, TwetenRK: Generation of a membrane-bound, oligomerized pre-pore complex is necessary for pore formation by Clostridium septicum α toxin.Mol. Microbiol.23 , 531–538 (1997).
  • Tweten RK : Clostridium perfringens β toxin and Clostridium septicum α toxin: their mechanisms and possible role in pathogenesis.Vet. Microbiol.82 , 1–9 (2001).
  • Kennedy CL , LyrasD, CordnerLM et al.: Pore-forming activity of α-toxin is essential for clostridium septicum-mediated myonecrosis.Infect. Immun.77 , 943–951 (2009).
  • Kennedy CL , SmithDJ, LyrasD, ChakravortyA, RoodJI: Programmed cellular necrosis mediated by the pore-forming α-toxin from Clostridium septicum.PLoS Pathog.5 , e1000516 (2009).
  • Knapp O , MaierE, Ben Mkaddem S et al.: Clostridium septicum α-toxin forms pores and induces rapid cell necrosis. Toxicon. (2009) (Epub ahead of print).
  • Wichroski MJ , MeltonJA, DonahueCG, TwetenRK, WardGE: Clostridium septicum α-toxin is active against the parasitic protozoan Toxoplasma gondii and targets members of the SAG family of glycosylphosphatidylinositol-anchored surface proteins.Infect. Immun.70 , 4353–4361 (2002).
  • Melton JA , TwetenRK: Clostridium septicum pore-forming α-toxin. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 623–630 (2006).
  • Lindsay JA : Clostridium perfringens type A enterotoxin (CPE): more than just explosive diarrhea.Crit. Rev. Microbiol.22 , 257–277 (1996).
  • Petit L , GibertM, PopoffMR: Clostridium perfringens enterotoxin and C. perfringens food poisoning. In: Encyclopedia of Food Microbiology. Robinson R, Batt C, Patel P (Eds). Academic Press, London, UK, 438–444 (1999).
  • Brynestad S , SarkerMR, McClaneBA, GranumPE, RoodJI: The enterotoxin (CPE) plasmid from Clostridium perfringens is conjugative.Infect. Immun.69 , 3483–3487 (2001).
  • Brynestad S , SynstadB, GranumPE: The Clostridium perfringens enterotoxin gene is on a transposable element in type A human food poisoning strains.Microbiology143 , 2109–2115 (1997).
  • Cornillot E , Saint-JoanisB, DaubeG, GranumPE, CanardB, ColeST: The enterotoxin gene (cpe) of Clostridium perfringens can be chromosomal or plasmid-borne.Mol. Microbiol.15 , 639–647 (1995).
  • Sparks SG , CarmanRJ, SarkerMR, McClaneBA: Genotyping of enterotoxigenic Clostridium perfringens fecal isolates associated with antibiotic-associated diarrhea and food poisoning in North America.J. Clin. Microbiol.39 , 883–888 (2001).
  • Collie RE , McClaneBA: Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with non-food-borne human gastrointestinal diseases.J. Clin. Microbiol.36 , 30–36 (1998).
  • Miyamoto K , FisherDJ, LiJ, SayeedS, AkimotoS, McClaneBA: Complete sequencing and diversity analysis of the enterotoxin-encoding plasmids in Clostridium perfringens type A non-food-borne human gastrointestinal disease isolates.J. Bacteriol.188 , 1585–1598 (2006).
  • Kobayashi S , WadaA, ShibasakiS et al.: Spread of a large plasmid carrying the cpe gene and the tcp locus amongst Clostridium perfringens isolates from nosocomial outbreaks and sporadic cases of gastroenteritis in a geriatric hospital.Epidemiol. Infect.137 , 108–113 (2009).
  • Li J , McClaneBA: Further comparison of temperature effects on growth and survival of Clostridium perfringens type A isolates carrying a chromosomal or plasmid-borne enterotoxin gene.Appl. Environ. Microbiol.72 , 4561–4568 (2006).
  • Li J , McClaneBA: Comparative effects of osmotic, sodium nitrite-induced, and pH-induced stress on growth and survival of Clostridium perfringens type A isolates carrying chromosomal or plasmid-borne enterotoxin genes.Appl. Environ. Microbiol.72 , 7620–7625 (2006).
  • Lahti P , HeikinheimoA, JohanssonT, KorkealaH: Clostridium perfringens type A strains carrying a plasmid-borne enterotoxin gene (genotype IS1151-cpe or IS1470-like-cpe) as a common cause of food poisoning.J. Clin. Microbiol.46 , 371–373 (2008).
  • Tanaka D , KimataK, ShimizuM et al.: Genotyping of Clostridium perfringens isolates collected from food poisoning outbreaks and healthy individuals in Japan based on the cpe locus.Jpn. J. Infect. Dis.60 , 68–69 (2007).
  • Nakamura M , KatoA, TanakaD et al.: PCR identification of the plasmid-borne enterotoxin gene (cpe) in Clostridium perfringens strains isolated from food poisoning outbreaks.Int. J. Med. Microbiol.294 , 261–265 (2004).
  • Kokai-Kun JF , McClaneBA: Deletion analysis of the Clostridium perfringens enterotoxin.Infect. Immun.65 , 1014–1022 (1997).
  • Hanna PC , MietznerTA, SchoolnikGK, McClaneBA: Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region.J. Biol. Chem.266 , 11037–11043 (1991).
  • Fujita K , KatahiraJ, HoriguchiY, SonodaN, FuruseM, TsukitaS: Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein.FEBS Lett.476 , 258–261 (2000).
  • Katahira J , InoueN, HoriguchiY, MatsudaM, SugimotoN: Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin.J. Cell Biol.136 , 1239–1247 (1997).
  • Sonoda N , FuruseM, SasakiH et al.: Clostridium perfringens enterotoxin fragment removes specific claudin from tight junction strands: evidence for direct involvement of claudin in tight junction barrier.J. Cell Biol.147 , 195–204 (1999).
  • Winkler L , GehringC, WenzelA et al.: Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3.J. Biol. Chem.284 , 18863–18872 (2009).
  • Van Itallie CM , BettsL, SmedleyJG 3rd, McClane BA, Anderson JM: Structure of the claudin-binding domain of Clostridium perfringens enterotoxin. J. Biol. Chem.283 , 268–274 (2008).
  • Caserta JA , HaleML, PopoffMR, StilesBG, McClaneBA: Evidence that membrane rafts are not required for the action of Clostridium perfringens enterotoxin.Infect. Immun.76 , 5677–5685 (2008).
  • Wieckowski EU , Kokai-KunJF, McClaneBA: Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment.Infect. Immun.66 , 5897–5905 (1998).
  • Singh U , Van Itallie CM, Mitic LL, Anderson JM, McClane BA: CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple complex species, one of which contains the tight junction protein occludin. J. Biol. Chem.275 , 18407–18417 (2000).
  • Smedley JG 3rd, Uzal FA, McClane BA: Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin. Infect. Immun.75 , 2381–2390 (2007).
  • Singh U , MiticLL, WieckowskiEU, AndersonJM, McClaneBA: Comparative biochemical and immunocytochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized CaCo-2 cells versus Vero cells.J. Biol. Chem.276 , 33402–33412 (2001).
  • Chakrabarti G , McClaneBA: The importance of calcium influx, calpain and calmodulin for the activation of CaCo-2 cell death pathways by Clostridium perfringens enterotoxin.Cell. Microbiol.7 , 129–146 (2005).
  • McClane BA : An overview of Clostridium perfringens enterotoxin.Toxicon34 , 1335–1343 (1996).
  • Smedley JG 3rd, Saputo J, Parker JC et al.: Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity. Infect. Immun.76 , 3793–3800 (2008).
  • Fernandez Miyakawa ME , Pistone Creydt V, Uzal FA, McClane BA, Ibarra C: Clostridium perfringens enterotoxin damages the human intestine in vitro.Infect. Immun.73 , 8407–8410 (2005).
  • Sayeed S , UzalFA, FisherDJ et al.: β toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model.Mol. Microbiol.67 , 15–30 (2008).
  • Fernandez-Miyakawa ME , FisherDJ, PoonR et al.: Both ε-toxin and β-toxin are important for the lethal properties of Clostridium perfringens type B isolates in the mouse intravenous injection model.Infect. Immun.75 , 1443–1452 (2007).
  • Fisher DJ , Fernandez-MiyakawaME, SayeedS et al.: Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model.Infect. Immun.74 , 5200–5210 (2006).
  • Vidal JE , McClaneBA, SaputoJ, ParkerJ, UzalFA: Effects of Clostridium perfringens β-toxin on the rabbit small intestine and colon.Infect. Immun.76 , 4396–4404 (2008).
  • Hunter SE , BrownE, OystonPCF, SakuraiJ, TitballRW: Molecular genetic analysis of β-toxin of Clostridium perfringens reveals sequence homology with α-toxin, γ-toxin, and leukocidin of Staphylococcus aureus.Infect. Immun.61 , 3958–3965 (1993).
  • Gibert M , PerelleS, DaubeG, PopoffMR: Clostridium spiroforme toxin genes are related to C. perfringens ι toxin genes but have a different genomic localization.Syst. Appl. Microbiol.20 , 337–347 (1997).
  • Katayama S , DupuyB, DaubeG, ChinaB, ColeS: Genome mapping of Clostridium perfringens strains with I-CeuI shows many virulence genes to be plamsid-borne.Mol. Gen. Genet.251 , 720–726 (1996).
  • Sakurai J , FujiiY, MatsuuraM: Effect of oxidizing agents and sulfhydryl group reagents on β toxin from Clostridium perfringens type C.Microbiol. Immunol.24 , 595–601 (1980).
  • Nagahama M , MiyawakiT, KiharaA et al.: Thiol group reagent-sensitive Clostridium perfringens β-toxin does not require a thiol group for lethal activity.Biochim. Biophys. Acta1454 , 97–105 (1999).
  • Steinthorsdottir V , FridiksdottirV, GunnarsonE, AndressonO: Site-directed mutagenesis of Clostridium perfringens β-toxin expression of wild type and mutant toxins in Bacillus subtilis.FEMS Microbiol. Lett.158 , 17–23 (1998).
  • Steinthorsdottir V , HalldorsonH, AndressonO: Clostridium perfringens β-toxin forms multimeric transmembrane pores in human endothelial cells.Microb. Pathog.28 , 45–50 (2000).
  • Shatursky O , BaylesR, RogersM, JostBH, SongerJG, TwetenRK: Clostridium perfringens β-toxin forms potential-dependent, cation-selective channels in lipid bilayers.Infect. Immun.68 , 5546–5551 (2000).
  • Nagahama M , HayashiH, MorimitsuS, SakuraiJ: Biological activities and pore formation of Clostridium perfringens β toxin in HL60 cells.J. Biol. Chem.278 , 36934–36941 (2003).
  • Nagahama M , MorimitsuS, KiharaA, AkitaM, SetsuK, SakuraiJ: Involvement of tachykinin receptors in Clostridium perfringens β-toxin-induced plasma extravasation.Br. J. Pharmacol.138 , 23–30 (2003).
  • Nagahama M , KiharaA, KintohH, OdaM, SakuraiJ: Involvement of tumour necrosis factor-α in Clostridium perfringens β-toxin-induced plasma extravasation in mice.Br. J. Pharmacol.153 , 1296–1302 (2008).
  • Gibert M , Jolivet-ReynaudC, PopoffMR: β2 toxin, a novel toxin produced by Clostridium perfringens.Gene203 , 65–73 (1997).
  • Herholz C , MiserezR, NicoletJ et al.: Prevalence of β2-toxigenic Clostridium perfringens in horses with intestinal disorders.J. Clin. Microbiol.37 , 358–361 (1999).
  • Vilei EM , SchlatterY, PerretenV et al.: Antibiotic-induced expression of a cryptic cpb2 gene in equine β2-toxigenic Clostridium perfringens.Mol. Microbiol.57 , 1570–1581 (2005).
  • Waters M , RajuD, GarmoryHS, PopoffMR, SarkerMR: Regulated expression of the β2-toxin gene (cpb2) in Clostridium perfringens type a isolates from horses with gastrointestinal diseases.J. Clin. Microbiol.43 , 4002–4009 (2005).
  • Bacciarini LN , BoerlinP, StraubR, FreyJ, GroneA: Immunohistochemical localization of Clostridium perfringens β2-toxin in the gastrointestinal tract of horses.Vet. Pathol.40 , 376–381 (2003).
  • van Asten AJ , NikolaouGN, GroneA: The occurrence of cpb2-toxigenic Clostridium perfringens and the possible role of the β2-toxin in enteric disease of domestic animals, wild animals and humans.Vet. J. (2008) (Epub ahead of print).
  • Lebrun M , FileeP, MoussetB et al.: The expression of Clostridium perfringens consensus β2 toxin is associated with bovine enterotoxaemia syndrome.Vet. Microbiol.120 , 151–157 (2007).
  • Harrison B , RajuD, GarmoryHS, BrettMM, TitballRW, SarkerMR: Molecular characterization of Clostridium perfringens isolates from humans with sporadic diarrhea: evidence for transcriptional regulation of the β2-toxin-encoding gene.Appl. Environ. Microbiol.71 , 8362–8370 (2005).
  • Fisher DJ , MiyamotoK, HarrisonB, AkimotoS, SarkerMR, McClaneBA: Association of β2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene.Mol. Microbiol.56 , 747–762 (2005).
  • Waters M , SavoieA, GarmoryHS et al.: Genotyping and phenotyping of β2-toxigenic Clostridium perfringens fecal isolates associated with gastrointestinal diseases in piglets.J. Clin. Microbiol.41 , 3584–3591 (2003).
  • Jolivet-Reynaud C , PopoffMR, VinitMA, RavisseP, MoreauH, AloufJE: Enteropathogenicity of Clostridium perfringens β toxin and other clostridial toxins.Zentralbl. Bakteriol.S15 , 145–151 (1986).
  • Keyburn AL , BoyceJD, VazP et al.: NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens.PLoS Pathog.4 , e26 (2008).
  • Manich M , KnappO, GibertM et al.: Clostridium perfringens δ toxin is sequence related to β toxin, NetB, and Staphylococcus pore-forming toxins, but shows functional differences.PLoS ONE3 , e3764 (2008).
  • Chalmers G , BruceHL, HunterDB et al.: Multilocus sequence typing analysis of Clostridium perfringens isolates from necrotic enteritis outbreaks in broiler chicken populations.J. Clin. Microbiol.46 , 3957–3964 (2008).
  • Truscott RB , Al-SheikhlyF: Reproduction and treatment of necrotic enteritis in broilers.Am. J. Vet. Res.38 , 857–861 (1977).
  • Al-Sheikhly F , TruscottRB: The interaction of Clostridium perfringens and its toxins in the production of necrotic enteritis of chickens.Avian Dis.21 , 256–263 (1977).
  • Keyburn AL , SheedySA, FordME et al.: α-toxin of Clostridium perfringens is not an essential virulence factor in necrotic enteritis in chickens.Infect. Immun.74 , 6496–6500 (2006).
  • Jolivet-Reynaud C , LaunayJM, AloufJE: Damaging effects of Clostridium perfringens δ toxin on blood platelets and their relevance to ganglioside GM2.Arch. Biochem. Biophys.262 , 59–66 (1988).
  • Jolivet C , AloufJE: Binding of Clostridium perfringens125I-labeled δ-toxin to erythrocytes.J. Biol. Chem.258 , 1871–1877 (1983).
  • Jolivet-Reynaud C , HauttecoeurB, AloufJ: Interaction of Clostridium perfringens δ-toxin with erythrocyte and liposome membranes and relation with the specific binding to the ganglioside GM2.Toxicon27 , 1113–1126 (1989).
  • Stevens DL , TroyerBE, MerrickDT, MittenJE, OlsonRD: Lethal effects and cardiovascular effects of purified α- and τ-toxins from Clostridium perfringens.J. Infect. Dis.157 , 272–279 (1988).
  • Flores-Diaz M , Alape-GironA: Role of Clostridium perfringens phospholipase C in the pathogenesis of gas gangrene.Toxicon42 , 979–986 (2003).
  • Shimizu-Reynaud T , OhtaniK, Ba-TheinW, InuiS, NakamuraS, HayashiH: Characterization of α toxin-deficient Clostridium perfringens strain, KZ1340.Microbiol. Immunol.40 , 141–145 (1996).
  • Brett MM : Outbreaks of food-poisoning associated with lecithinase-negative Clostridium perfringens.J. Med. Microbiol.41 , 405–407 (1994).
  • Justin N , WalkerN, BullifentHL et al.: The first strain of Clostridium perfringens isolated from an avian source has an α-toxin with divergent structural and kinetics properties.Biochemistry41 , 6253–6262 (2002).
  • Abildgaard L , EngbergRM, PedersenK, SchrammA, HojbergO: Sequence variation in the α-toxin encoding plc gene of Clostridium perfringens strains isolated from diseased and healthy chickens.Vet. Microbiol.136 , 293–299 (2008).
  • Sheedy SA , InghamAB, RoodJI, MooreRJ: Highly conserved α-toxin sequences of avian isolates of Clostridium perfringens.J. Clin. Microbiol.42 , 1345–1347 (2004).
  • Naylor CE , EatonJT, HowellsA et al.: Structure of the key toxin in gas gangrene.Nat. Struct. Biol.5 , 738–746 (1998).
  • Titball RW , LeslieDL, HarveyS, KellyD: Hemolytic and sphingomyelinase activities of Clostridium perfringens α-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway.Infect. Immun.59 , 1872–1874 (1991).
  • Guillouard I , GarnierT, ColeS: Use of site-directed mutagenesis to probe structure–function relationship of α-toxin from Clostridium perfringens.Infect. Immun.64 , 2440–2444 (1996).
  • Nagahama M , NakayamaT, MichiueK, SakuraiJ: Site-specific mutagenesis of Clostridium perfringens α-toxin: replacement of Asp-56, Asp-130, or Glu-152 causes loss of enzymatic and hemolytic activites.Infect. Immun.65 , 3489–3492 (1997).
  • Nagahama MY , OkagawaT, NakayamaT, NishiokaE, SakuraiJ: Site directed mutagenesis of histidine residues in Clostridium perfringens α-toxin.J. Bacteriol.177 , 1179–1185 (1995).
  • Eaton JT , NaylorCE, HowellsAM, MossDS, TitballRW, BasakAK: Crystal structure of the C. perfringens α-toxin with the active site closed by a flexible loop region.J. Mol. Biol.319 , 275–281 (2002).
  • Titball RW : Biochemical and immunological properties of the C-terminal domain of the α-toxin of Clostridium perfringens.FEMS Microbiol. Lett.110 , 45–50 (1993).
  • Nagahama M , MukaiM, MorimitsuS, OchiS, SakuraiJ: Role of the C-domain in the biological activities of Clostridium perfringens α-toxin.Microbiol. Immunol.46 , 647–655 (2002).
  • Moreau H , PieroniG, Jolivet-ReynaudC, AloufJE, VergerR: A new kinetic approach for studying phospholipase C (Clostridium perfringens α toxin) activity on phospholipid monolayers.Biochemistry27 , 2319–2323 (1988).
  • Nagahama M , MichiueK, MukaiM, OchiS, SakuraiJ: Mechanism of membrane damage by Clostridium perfringens α-toxin.Microbiol. Immunol.42 , 533–538 (1998).
  • Jepson M , HowellsA, BullifentHL et al.: Differences in the carboxy-terminal (putative phospholipid binding) domains of Clostridium perfringens and Clostridium bifermentans phospholipases C influence the hemolytic and lethal properties of these enzymes.Infect. Immun.67 , 3297–3301 (1999).
  • Guillouard I , AlzariPM, SaliouB, ColeST: The carboxy-terminal C2-like domain of the α-toxin from Clostridium perfringens mediates calcium-dependent membrane recognition.Mol. Microbiol.26 , 867–876 (1997).
  • Williamson ED , TitballRW: A genetically engineered vaccine against the α-toxin of Clostridium perfringens also protects mice against experimental gas gangrene.Vaccine11 , 1253–1258 (1993).
  • Titball RW , NaylorCE, BasakAK: The Clostridium perfringens α-toxin.Anaerobe5 , 51–64 (1999).
  • Nagahama M , MichiueK, SakuraiJ: Membrane-damaging action of Clostridium perfringens α-toxin on phospholipid liposomes.Biochim. Biophys. Acta1280 , 120–126 (1996).
  • Nagahama M , OtsukaA, OdaM et al.: Effect of unsaturated bonds in the sn-2 acyl chain of phosphatidylcholine on the membrane-damaging action of Clostridium perfringens α-toxin toward liposomes.Biochim. Biophys. Acta1768 , 2940–2945 (2007).
  • Sakurai J , OchiS, TanakaH: Evidence for coupling of Clostridium perfringens α-toxin-induced hemolysis to stimulated phosphatidic acid formation in rabbit erythrocytes.Infect. Immun.61 , 3711–3718 (1993).
  • Ochi S , HashimotoK, NagahamaM, SakuraiJ: Phospholipid metabolism induced by Clostridium perfringens α-toxin elicits a hot cold type of hemolysis in rabbit erythrocytes.Infect. Immun.64 , 3930–3933 (1996).
  • Oda M , MatsunoT, ShiiharaR et al.: The relationship between the metabolism of sphingomyelin species and the hemolysis of sheep erythrocytes induced by Clostridium perfringens α-toxin.J. Lipid Res.49 , 1039–1047 (2008).
  • Sakurai J , NagahamaM, OdaM: Clostridium perfringens α-toxin: characterization and mode of action.J. Biochem.136 , 569–574 (2004).
  • Oda M , IkariS, MatsunoT, MorimuneY, NagahamaM, SakuraiJ: Signal transduction mechanism involved in Clostridium perfringens α-toxin-induced superoxide anion generation in rabbit neutrophils.Infect. Immun.74 , 2876–2886 (2006).
  • O‘Brien DK , MelvilleSB: Effects of Clostridium perfringens α-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.Infect. Immun.72 , 5204–5215 (2004).
  • Bryant AE , BayerCR, Hayes-SchroerSM, StevensD: Activation of platelet gpIIIa by phospholipase C from Clostridium perfringens involves store-operated calcium entry.J. Infect. Dis.187 , 408–417 (2003).
  • Bryant AE , ChenRYZ, NagataY et al.: Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene.J. Infect. Dis.182 , 808–815 (2000).
  • Bryant AE , ChenRYZ, NagataY et al.: Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens.J. Infect. Dis.182 , 799–807 (2000).
  • Bunting M , LorantDE, BryantAE et al.: A toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells.J. Clin. Invest.100 , 565–574 (1997).
  • Abe A , MatsuzawaT, KuwaeA: Type-III effectors: sophisticated bacterial virulence factors.C. R. Biol.328 , 413–428 (2005).
  • Flores-Diaz M , Alape-GironA, TitballRW et al.: UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipase C.J. Biol. Chem.273 , 24433–24438 (1998).
  • Matsushita O , JungCM, KatayamaS, MinamiJ, TakahashiY, OkabeA: Gene duplication and multiplicity of collagenases in Clostridium histolyticum.J. Bacteriol.181, 923–933 (1999).
  • Jung CM , MatsushitaO, KatayamaS, MinamiJ, SakuraiJ, OkabeA: Identification of metal ligands in the Clostridium histolyticum ColH collagenase.J. Bacteriol.181 , 2816–2822 (1999).
  • Matsushita O , JungCM, MinamiJ, KatayamaS, NishiN, OkabeA: A study of the collagen-binding domain of a 116 kDa Clostridium histolyticum collagenase.J. Biol. Chem.273 , 3643–3648 (1998).
  • Matsushita O , OkabeA: Clostridial hydrolytic enzymes degrading extracellular components.Toxicon39 , 1769–1780 (2001).
  • Wilson JJ , MatsushitaO, OkabeA, SakonJ: A bacterial collagen-binding domain with novel calcium-binding motif controls domain orientation.EMBO J.22 , 1743–1752 (2003).
  • Matsushita O , YoshiharaK, KatayamaS, MinamiJ, OkabeA: Purification and characterization of a Clostridium perfringens 120-kilodalton collagenase and nucleotide sequence of the corresponding gene.J. Bacteriol.176 , 149–156 (1994).
  • Awad MM , EllemorDM, BryantAE et al.: Construction and virulence testing of a collagenase mutant of Clostridium perfringens.Microb. Pathog.28 , 107–117 (2000).
  • Okumura K , OhtaniK, HayashiH, ShimizuT: Characterization of genes regulated directly by the VirR/VirS system in Clostridium perfringens.J. Bacteriol.190 , 7719–7727 (2008).
  • Petit L , GibertM, PopoffMR: Clostridium perfringens: toxinotype and genotype.Trends Microbiol.7 , 104–110 (1999).
  • Popoff MR : Molecular biology of actin-ADP-ribosylating toxins. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 275–302 (2000).
  • Barth H , AktoriesK, PopoffMR, StilesBG: Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.Microbiol. Mol. Biol. Rev.68 , 373–402 (2004).
  • Popoff MR , StilesBG: Bacterial toxins and virulence factors targetting the actin cytoskeleton and intercellular junctions. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 154–187 (2006).
  • Gibert M , PetitL, RaffestinS, OkabeA, PopoffMR: Clostridium perfringens ι-toxin requires activation of both binding and enzymatic components for cytopathic activity.Infect. Immun.68 , 3848–3853 (2000).
  • Ohishi I : Structure and function of actin-adenosine-diphosphate-ribosylating toxins. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 253–273 (2000).
  • Petosa C , CollierJR, KlimpelKR, LepplaSH, LiddingtonRC: Crystal structure of the anthrax toxin protective antigen.Nature385 , 833–838 (1997).
  • Cunningham K , LacyDB, MogridgeJ, CollierRJ: Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen.Proc. Natl Acad. Sci. USA99 , 7049–7053 (2002).
  • Abrami L , LiuS, CossonP, LepplaSH, van der Goot FG: Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol.160 , 321–328 (2003).
  • Mogridge J , CuninghamK, LacyDB, MourezM, CollierRJ: The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.Proc. Natl Acad. Sci. USA99 , 7045–7048 (2002).
  • Mogridge J , CunninghamK, CollierRJ: Stoichiometry of anthrax toxin complexes.Biochemistry41 , 1079–1082 (2002).
  • Schleberger C , HochmannH, BarthH, AktoriesK, SchulzGE: Structure and action of the binary C2 toxin from Clostridium botulinum.J. Mol. Biol.364 , 705–715 (2006).
  • Blöcker D , BarthH, MaierE, BenzR, BarbieriJT, AktoriesK: The C terminus of component C2II of Clostridium botulinum C2 toxin is essential for receptor binding.Infect. Immun.68 , 4566–4573 (2000).
  • Marvaud JC , SmithT, HaleML, PopoffMR, SmithLA, StilesBG: Clostridium perfringens ι-toxin: mapping of receptor binding and Ia docking domains on Ib.Infect. Immun.69 , 2435–2441 (2001).
  • Stiles B , HaleML, MarvaudJC, PopoffMR: Clostridium perfringens ι toxin: binding studies and characterization of cell surface receptor by fluorescence-activated cytometry.Infect. Immun.68 , 3475–3484 (2000).
  • Eckhardt M , BarthH, BlöckerD, AktoriesK: Binding of Clostridium botulinum C2 toxin to asparagine-linked complex and hybrid carbohydrates.J. Biol. Chem.275 , 2328–2334 (2000).
  • Barth H , HofmannF, OlenikC, JustI, AktoriesK: The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin.Infect. Immun.66 , 1364–1369 (1998).
  • Han S , CraigJA, PutnamCD, CarozziNB, TainerJA: Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex.Nat. Struct. Biol.6 , 932–936 (1999).
  • Tsuge H , NagahamaM, NishimuraH et al.: Crystal structure and site-directed mutagenesis of enzymatic components from Clostridium perfringens ι-toxin.J. Mol. Biol.325 , 471–483 (2003).
  • Marvaud JC , StilesBG, ChenalA et al.: Clostridium perfringens ι toxin: mapping of the Ia domain involved in docking with Ib and cellular internalization.J. Biol. Chem.277 , 43659–43666 (2002).
  • Barth H , RoeblingR, FritzM, AktoriesK: The binary Clostridium botulinum C2 toxin as a protein delivery system.J. Biol. Chem.277 , 5074–5081 (2002).
  • Tsuge H , NagahamaM, OdaM et al.: Structural basis of actin recognition and arginine ADP-ribosylation by Clostridium perfringens ι-toxin.Proc. Natl Acad. Sci. USA105 , 7399–7404 (2008).
  • Perelle S , GibertM, BoquetP, PopoffMR: Characterization of Clostridium perfringens ι-toxin genes and expression in Escherichia coli.Infect. Immun.61 , 5147–5156 (Author‘s correction: 63 , 4967 [1995]) (1993).
  • Simpson LL , StilesBG, ZepedaHH, WilkinsTD: Molecular basis for the pathological actions of Clostridium perfringens ι toxin.Infect. Immun.55 , 118–122 (1987).
  • Bachmeyer C , BenzR, BarthH, AktoriesK, GibertM, PopoffMR: Interaction of Clostridium botulinum C2 toxin with lipid bilayer membranes and Vero cells: inhibition of channel function in chloroquine and related compounds in vitro and toxin action in vivo.FASEB J.15 , 1658–1660 (2001).
  • Barth H , BlöckerD, BehlkeJ et al.: Cellular uptake of Clostridium botulinum C2 toxin requires oligomerization and acidification.J. Biol. Chem.275 , 18704–18711 (2000).
  • Knapp O , BenzR, GibertM, MarvaudJC, PopoffMR: Interaction of Clostridium perfringens ι-toxin with lipid bilayer membranes.J. Biol. Chem.277 , 6143–6152 (2002).
  • Schmid A , BenzR, JustI, AktoriesK: Interaction of Clostridium botulinum C2 toxin with lipid bilayer membranes.J. Biol. Chem.269 , 16706–16711 (1994).
  • Gibert M , MarvaudJC, PereiraY et al.: Differential requirement for the translocation of clostridial binary toxins: ι toxin requires a membrane potential gradient.FEBS Lett.581 , 1287–1296 (2007).
  • Ohishi I : Activation of botulinum C2 toxin by trypsin.Infect. Immun.55 , 1461–1465 (1987).
  • Stiles BG , HaleML, MarvaudJC, PopoffMR: Clostridium perfringens ι toxin: characterization of the cell-asociated ι b complex.Biochem. J.367 , 801–808 (2002).
  • Neumeyer T , SchifflerB, MaierE, LangAE, AktoriesK, BenzR: Clostridium botulinum C2 toxin. Identification of the binding site for chloroquine and related compounds and influence of the binding site on properties of the C2II channel.J. Biol. Chem.283 , 3904–3914 (2008).
  • Lang AE , NeumeyerT, SunJ, CollierRJ, BenzR, AktoriesK: Amino acid residues involved in membrane insertion and pore formation of Clostridium botulinum C2 toxin.Biochemistry47 , 8406–8413 (2008).
  • Kaiser E , HaugG, HliscsM, AktoriesK, BarthH: Formation of a biologically active toxin complex of the binary Clostridium botulinum C2 toxin without cell membrane interaction.Biochemistry45 , 13361–13368 (2006).
  • Haug G , AktoriesK, BarthH: The host cell chaperone Hsp90 is necessary for cytotxic action of the binary ι-like toxins.Infect. Immun.72 , 3066–3068 (2004).
  • Haug G , LeemhuisJ, TiemannD, MeyerDK, AktoriesK, BarthH: The host cell chaperone Hsp90 is essential for translocation of the binary Clostridium botulinum C2 toxin into the cytosol.J. Biol. Chem.278 , 32266–32274 (2003).
  • Ratts R , ZengH, BergEA et al.: The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex.J. Cell Biol.160 , 1139–1150 (2003).
  • Richard JF , MainguyG, GibertM, MarvaudJC, StilesBG, PopoffMR: Transcytosis of ι toxin across polarized CaCo-2 cell monolayers.Mol. Microbiol.43 , 907–917 (2002).
  • Reuner KH , DunkerP, van der Does A et al.: Regulation of actin synthesis in rat hepatocytes by cytoskeleton rearrangements. Eur. J. Cell Biol.69 , 189–196 (1996).
  • Kiefer G , LernerM, SehrP, JustI, AktoriesK: Cytotoxic effects by microinjection of ADP-ribosylated skeletal muscle G-actin in PtK2 cells in the absence of Clostridium perfringens ι toxin.Med. Microbiol. Immunol.184 , 175–180 (1996).
  • Uematsu Y , KogoY, OhishiI: Disassembly of actin filaments by botulinum C2 toxin and actin-filament-disrupting agents induces assembly of microtubules in human leukaemia cell lines.Biol. Cell99 , 141–150 (2007).
  • Barth H , KlingerM, AktoriesK, KinzelV: Clostridium botulinum C2 toxin delays entry into mitosis and activation of p34cdc2 kinase and cdc25-C phosphatase in Hela cells.Infect. Immun.67 , 5083–5090 (1999).
  • Vershueren H , van der Taelen I, Dewit J et al.: Effects of Clostridium botulinum C2 toxin and cytochalasin D on in vitro invasiveness, motility and F-actin content of a murine T-lymphoma cell line. Eur. J. Cell Biol.66 , 335–341 (1995).
  • Mauss S , KochG, KreyeVAW, AktoriesK: Inhibition of the contraction of the isolated longitudinal muscle of the guinea-pig ileum by botulinum C2 toxin: evidence for a role of G/F-actin transition in smooth muscle contraction.Naunyn Schmiedebergs Arch. Pharmacol.340 , 345–351 (1989).
  • Ermert L , BrücknerH, WalmrathD et al.: Role of endothelial cytoskeleton in high-permeability edema due to botulism C2 toxin in perfused rabbit lungs.Am. J. Physiol.268 , L753–L761 (1995).
  • Aktories K , KochG: Modification of actin and Rho proteins by clostridial ADP-ribosylating toxins. In: Bacterial Toxins and Virulence Factors in Disease. Iglewski B, Moss J, Vaughan M (Eds). Marcel Dekker, NY, USA, 491–520 (1995).
  • Vogelsgesang M , PautschA, AktoriesK: C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins.Naunyn Schmiedebergs Arch. Pharmacol.374 , 347–360 (2007).
  • Han S , ArvaiAS, ClancySB, TainerJA: Crystal structure and novel recognition motif of Rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.J. Mol. Biol.305 , 95–107 (2001).
  • Vogelsgesang M , StieglitzB, HerrmannC, PautschA, AktoriesK: Crystal structure of the Clostridium limosum C3 exoenzyme.FEBS Lett.582 , 1032–1036 (2008).
  • Evans HR , HollowayDE, SuttonJM, AyrissJ, ShoneCC, AcharyaKR: C3 exoenzyme from Clostridium botulinum: structure of a tetragonal crystal form and a reassessment of NAD-induced flexure.Acta Crystallogr. D Biol. Crystallogr.60 , 1502–1505 (2004).
  • Evans HR , SuttonJM, HollowayDE, AyrissJ, ShoneCC, AcharyaKR: The crystal structure of C3stau2 from Staphylococcus aureus and its complex with NAD.J. Biol. Chem.278 , 45924–45930 (2003).
  • Ménétrey J , FlatauG, SturaEA et al.: NAD binding induces conformational changes in Rho ADP-ribosylating Clostridium botulinum C3 exoenzyme.J. Biol. Chem.277 , 30950–30957 (2002).
  • Menetrey J , FlatauG, BoquetP, MenezA, SturaEA: Structural basis for the NAD-hydrolysis mechanism and the ARTT-loop plasticity of C3 exoenzymes.Protein Sci.17 , 878–886 (2008).
  • Wilde C , ChhatwalGS, SchmalzingG, AktoriesK, JustI: A novel C3-like ADP-ribosyltransferase from Staphyloccocus aureus modifyng RhoE and Rnd3.J. Biol. Chem.276 , 9537–9542 (2001).
  • Aktories K , JustI: Clostridial Rho-inhibiting protein toxins.Curr. Top. Microbiol. Immunol.291 , 113–145 (2005).
  • Hall A : Rho GTPases and the actin cytoskeleton.Science279 , 509–514 (1998).
  • Wei Y , ZhangY, DerewendaU et al.: Crystal structure of RhoA-GDP and its functional implications.Nat. Struct. Biol.4 , 699–703 (1997).
  • Bourmeyster N , StrasiaMJ, GarinJ, GagnonJ, BoquetP, VignaisP: Copurification of Rho protein and the Rho GDP dissociation inhibitor from bovine neutrophil cytosol. Effects of phosphoinositides on Rho ADP-ribosylation by the C3 exoenzyme of Clostridium botulinum.Biochemistry31 , 12863–12869 (1992).
  • Ren XD , BokochGM, Traynor-KaplanA, JenkinsGH, AndersonRA, SchwartzMA: Physical association of the small GTPase Rho with a 68-kDa phosphatidylinositol 4-phosphate 5-kinase in swiss 3T3 cells.Mol. Biol. Cell7 , 435–442 (1996).
  • Sehr P , GiliJ, GenthH, JustI, PickE, AktoriesK: Glucosylation and ADP ribosylation of Rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling.Biochemistry37 , 5296–5304 (1998).
  • Genth H , SchmidtM, GerhardR, AktoriesK, JustI: Activation of phospholipase D1 by ADP-ribosylated RhoA.Biochem. Biophys. Res. Commun.302 , 127–132 (2003).
  • Genth H , GerhardR, MaedaA et al.: Entrapment of Rho ADP-ribosylated by Clostridium botulinum C3 exoenzyme in the Rho-guanine nucleotide dissociation inhibitor-1 complex.J. Biol. Chem.278 , 28523–28527 (2003).
  • Fujihara H , WalkerLA, GongMC et al.: Inhibition of RhoA translocation and calcium sensitization by in vivo ADP-ribosylation with the chimeric toxin DC3B.Mol. Biol. Cell8 , 2437–2447 (1997).
  • Barth H , OlenikC, SehrP, SchmidtG, AktoriesK, MeyerDK: Neosynthesis and activation of Rho by Escherichia coli cytotoxic necrotizing factor (CNF1) reverse cytopathic effects of ADP-ribosylated Rho.J. Biol. Chem.274 , 27407–27414 (1999).
  • Holbourn KP , SuttonJM, EvansHR, ShoneCC, AcharyaKR: Molecular recognition of an ADP-ribosylating Clostridium botulinum C3 exoenzyme by RalA GTPase.Proc. Natl Acad. Sci. USA102 , 5357–5362 (2005).
  • Pautsch A , VogelsgesangM, TrankleJ, HerrmannC, AktoriesK: Crystal structure of the C3bot–RalA complex reveals a novel type of action of a bacterial exoenzyme.EMBO J.24(20) , 3670–3680 (2005).
  • Ahnert-Hilger G , HoltjeM, GrosseG et al.: Differential effects of Rho GTPases on axonal and dendritic development in hippocampal neurones.J. Neurochem.90 , 9–18 (2004).
  • Holtje M , DjalaliS, HofmannF et al.: A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation.FASEB J.23 , 1115–1126 (2009).
  • Chardin P , BoquetP, MadauleP, PopoffMR, RubinEJ, GillDM: The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells.EMBO J.8 , 1087–1092 (1989).
  • Ridley AJ , HallA: The small GTP-binding protein Rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.Cell70 , 389–399 (1992).
  • Fukata M , KaibuchiK: Rho-family GTPases in cadherin-mediated cell–cell adhesion.Nat. Rev. Mol. Cell Biol.2 , 887–897 (2001).
  • Aktories K , BarthH, JustI: Clostridium botulinum C3 exoenzyme and C3-like transferases. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 207–233 (2000).
  • Aktories K , WildeC, VogelsgesangM: Rho-modifying C3-like ADP-ribosyltransferases.Rev. Physiol. Biochem. Pharmacol.152 , 1–22 (2004).
  • Boyer L , DoyeA, RolandoM et al.: Induction of transient macroapertures in endothelial cells through RhoA inhibition by Staphylococcus aureus factors.J. Cell Biol.173 , 809–819 (2006).
  • Czech A , YamaguchiT, BaderL et al.: Prevalence of Rho-inactivating epidermal cell differentiation inhibitor toxins in clinical Staphylococcus aureus isolates.J. Infec. Dis.184 , 785–788 (2001).
  • O ‘Neill AJ , LarsenAR, SkovR, HenriksenAS, ChopraI: Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus.J. Clin. Microbiol.45 , 1505–1510 (2007).
  • Jank T , AktoriesK: Structure and mode of action of clostridial glucosylating toxins: the ABCD model.Trends Microbiol.16 , 222–229 (2008).
  • Amimoto K , NoroT, OishiE, ShimizuM: A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C.Microbiology153 , 1198–1206 (2007).
  • Na X , KimH, MoyerMP, PothoulakisC, LaMontJT: gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A.Infect. Immun.76 , 2862–2871 (2008).
  • Greco A , HoJG, LinSJ, PalcicMM, RupnikM, NgKK: Carbohydrate recognition by Clostridium difficile toxin A.Nat. Struct. Mol. Biol.13 , 460–461 (2006).
  • Ho JG , GrecoA, RupnikM, NgKK: Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.Proc. Natl Acad. Sci. USA102 , 18373–18378 (2005).
  • Hofmann F , BuschC, AktoriesK: Chimeric clostridial cytotoxins: identification of the N-terminal region involved in protein substrate recognition.Infect. Immun.66 , 1076–1081 (1998).
  • Hofmann F , BuschC, PrepensU, JustI, AktoriesK: Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin.J. Biol. Chem.272 , 11074–11078 (1997).
  • Rupnik M , PabstS, RupnikM, von Eichel-Streiber C, Urlaub H, Soling HD: Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology151 , 199–208 (2005).
  • Ziegler MO , JankT, AktoriesK, SchulzGE: Conformational changes and reaction of clostridial glycosylating toxins.J. Mol. Biol.377 , 1346–1356 (2008).
  • Reinert DJ , JankT, AktoriesK, SchulzGE: Structural basis for the function of Clostridium difficile toxin B.J. Mol. Biol.351 , 973–981 (2005).
  • Just I , HofmannF, AktoriesK: Molecular mechanism of action of the large clostridial cytotoxins. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 307–331 (2000).
  • Busch C , SchömigK, HofmannF, AktoriesK: Characterization of the catalytic domain of Clostridium novyi α toxin.Infect. Immun.68 , 6378–6383 (2000).
  • Busch C , HofmannF, GerhardR, AktoriesK: Involvement of a conserved tryptophan residue in the UDP-glucose binding of large clostridial cytotoxin glycosyltransferases.J. Biol. Chem.275 , 13228–13234 (2000).
  • Jank T , GiesemannT, AktoriesK: Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding.J. Biol. Chem.282 , 35222–35231 (2007).
  • Jank T , ReinertDJ, GiesemannT, SchulzGE, AktoriesK: Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesis.J. Biol. Chem.280(45) , 37833–37838 (2005).
  • Mesmin B , RobbeK, GenyB et al.: A phosphatidylserine-binding site in the cytosolic fragment of Clostridium sordellii lethal toxin facilitates glucosylation of membrane-bound Rac and is required for cytotoxicity.J. Biol. Chem.279 , 49876–49882 (2004).
  • Müller S , von Eichel-Streiber C, Moos M: Impact of amino acids 22–27 of rho subfamily GTPases on glucosylation by the large clostridial cytotoxins TcsL-1522, TcdB-1470 and tcdB-8864. Eur. J. Biochem.266 , 1073–1080 (1999).
  • Barth H , PfeiferG, HofmannF, MaierE, BenzR, AktoriesK: Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells.J. Biol. Chem.276 , 10670–10676 (2001).
  • Fiorentini C , ThelestamM: Clostridium difficile toxin A and its effects on cells.Toxicon29 , 543–567 (1991).
  • Popoff MR , Chaves-OlarteE, LemichezE et al.: Ras, Rap, and rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation.J. Biol. Chem.271 , 10217–10224 (1996).
  • Qa‘dan M , SpyresLM, BallardJD: pH-induced conformational changes in Clostridium difficile toxin B.Infect. Immun.68 , 2470–2474 (2000).
  • Qa‘dan M , SpyresLM, BallardJD: pH-induced cytopathic effects of Clostridium sordellii lethal toxin.Infect. Immun.69 , 5487–5493 (2001).
  • Giesemann T , JankT, GerhardR et al.: Cholesterol-dependent pore formation of Clostridium difficile toxin A.J. Biol. Chem.281 , 10808–10815 (2006).
  • Egerer M , GiesemannT, HerrmannC, AktoriesK: Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.J. Biol. Chem.284 , 3389–3395 (2009).
  • Egerer M , GiesemannT, JankT, SatchellKJ, AktoriesK: Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity.J. Biol. Chem.282 , 25314–25321 (2007).
  • Reineke J , TenzerS, RupnikM et al.: Autocatalytic cleavage of Clostridium difficile toxin B.Nature446 , 415–419 (2007).
  • Just I , SelzerJ, WilmM, von Eichel-Streiber C, Mann M, Aktories K: Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature375 , 500–503 (1995).
  • Just I , WilmM, SelzerJ et al.: The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins.J. Biol. Chem.270 , 13932–13936 (1995).
  • Hermann C , AhmadianMR, HofmannF, JustI: Functional consequences of monoglucosylation of Ha-Ras at effector domain amino acid threonine 35.J. Biol. Chem.273 , 16134–16139 (1998).
  • Vetter IR , HofmannF, WohlgemuthS, HermannC, JustI: Structural consequences of monoglucosylation of Ha-Ras by Clostridium sordellii lethal toxin.J. Mol. Biol.301 , 1091–1095 (2000).
  • Genth H , AktoriesK, JustI: Monoglucosylation of RhoA at threonine 37 blocks cytosol membrane recycling.J. Biol. Chem.274 , 29050–29056 (1999).
  • Halabi-Cabezon I , HuelsenbeckJ, MayM et al.: Prevention of the cytopathic effect induced by Clostridium difficile Toxin B by active Rac1.FEBS Lett.582 , 3751–3756 (2008).
  • Chen ML , PothoulakisC, LaMontJT: Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A.J. Biol. Chem.277 , 4247–4254 (2002).
  • Nusrat A , von Eichel-Streiber C, Turner JR, Verkade P, Madara JL, Parkos CA: Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect. Immun.69 , 1329–1336 (2001).
  • Boehm C , GibertM, GenyB, PopoffMR, RodriguezP: Modification of epithelial cell barrier permeability and intercellular junctions by Clostridium sordellii lethal toxin.Cell. Microbiol.8 , 1070–1085 (2006).
  • Geny B , KhumH, FittingC et al.: Clostridium sordellii lethal toxin kills mice by inducing a major increase in lung vascular permeability.Am. J. Pathol.170 , 1003–1017 (2007).
  • Nottrott S , SchoentaubeJ, GenthH, JustI, GerhardR: Clostridium difficile toxin A-induced apoptosis is p53-independent but depends on glucosylation of Rho GTPases.Apoptosis12 , 1443–1453 (2007).
  • Gerhard R , NottrottS, SchoentaubeJ, TatgeH, OllingA, JustI: Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells.J. Med. Microbiol.57 , 765–770 (2008).
  • Kim H , RheeSH, PothoulakisC, LamontJT: Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand.Gastroenterology133 , 875–886 (2007).
  • Genth H , DregerSC, HuelsenbeckJ, JustI: Clostridium difficile toxins: more than mere inhibitors of Rho proteins.Int. J. Biochem. Cell Biol.40 , 592–597 (2008).
  • Matarrese P , FalzanoL, FabbriA et al.: Clostridium difficile toxin B causes apoptosis in epithelial cells by thrilling mitochondria: involvement of ATP-sensitive mitochondrial potassium channels.J. Biol. Chem.282 , 9029–9041 (2007).
  • Petit P , BreardJ, MontalescolV et al.: Lethal toxin from Clostridium sordellii induces apoptotic cell death by disruption of mitochondrial homeostasis in HL-60 cells.Cell. Microbiol.5 , 761–771 (2003).
  • Just I , GerhardR: Large clostridial cytotoxins.Rev. Physiol. Biochem. Pharmacol.152 , 23–47 (2004).
  • Gerhard R , TatgeH, GenthH et al.: Clostridium difficile toxin A induces expression of the stress-induced early gene product RhoB.J. Biol. Chem.280 , 1499–1505 (2005).
  • Huelsenbeck J , DregerSC, GerhardR, FritzG, JustI, GenthH: Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile.Biochemistry46 , 4923–4931 (2007).
  • Pothoulakis C , LamontJT: Microbes and microbial toxins: paradigms for microbial-mucosa interactions II. The integrated response of the intestine to Clostridium difficile toxins.Am. J. Physiol. Gastrointest. Liver Physiol.280 , G178–G183 (2001).
  • Savidge TC , PanWH, NewmanP, O‘BrienM, AntonPM, PothoulakisC: Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine.Gastroenterology125 , 413–420 (2003).
  • Warny M , KeatesAC, KeatesS et al.: p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis.J. Clin. Invest.105 , 1147–1156 (2000).
  • Na X , ZhaoD, KoonHW et al.: Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes.Gastroenterology128 , 1002–1011 (2005).
  • Wershil B , CastagliuoloI, PothoulakisC: Mast cell involvement in Clostridium difficile toxin A-induced intestinal fluid secretion and neutrophil recruitment in mice.Gastroenterology114 , 956–964 (1998).
  • He D , HagenSJ, PothoulakisC et al.: Clostridium difficile toxin A causes early damage to mitochondria in cultured cells.Gastroenterology119 , 139–150 (2000).
  • Geny B , PopoffMR: Activation of a c-Jun-NH2-terminal kinase pathway by the lethal toxin from Clostridium sordellii, TcsL-82, occurs independently of the toxin intrinsic enzymatic activity and facilitates small GTPase glucosylation.Cell. Microbiol.11(7) , 1102–1113 (2009).
  • Ben El Hadj N , PopoffMR, MarvaudJC et al.: G-protein-stimulated phospholipase D activity is inhibited by lethal toxin from Clostridium sordellii in HL-60 cells.J. Biol. Chem.274 , 14021–14031 (1999).
  • Schmidt M , VosM, ThielM et al.: Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordellii lethal toxin and Clostridium difficile toxin B-1470 in HEK-293 cells.J. Biol. Chem.273 , 7413–7422 (1998).
  • Kim JH , LeeSD, HanJM et al.: Activation of phospholipase D1 by direct interaction with ADP-ribosylation factor 1 and RalA.FEBS J.430 , 231–235 (1998).
  • Luo JQ , LiuX, HammondSM et al.: RalA interacts directly with the Arf-responsive, PIP2-dependent phospholipase D1.Biochem. Biophys. Res. Commun.235 , 854–859 (1997).
  • Kelly CP , LaMontJT: Clostridium difficile – more difficult than ever.N. Engl. J. Med.359 , 1932–1940 (2008).
  • Voth DE , BallardJD: Clostridium difficile toxins: mechanism of action and role in disease.Clin. Microbiol. Rev.18 , 247–263 (2005).
  • Lyras D , O‘ConnorJR, HowarthPM et al.: Toxin B is essential for virulence of Clostridium difficile.Nature458(7242) , 1176–1179 (2009).
  • Songer JG : Clostridial diseases in domestic animals. In: Handbook on Clostridia. Dürre P (Ed.). CRC Press, Taylor and Francis Group, FL, USA, 527–542 (2005).
  • Clark S : Sudden death in periparturient sheep associated with Clostridium sordellii.Vet. Rec.153 , 340 (2003).
  • Lewis CJ , NaylorRD: Sudden death in sheep associated with Clostridium sordellii.Vet. Rec.142 , 417–421 (1998).
  • Lewis CJ , NaylorR: Sudden death in lambs associated with Clostridium sordellii infection.Vet. Rec.138 , 262 (1996).
  • Al-Mashat RR , TaylorDJ: Production of diarrhea and enteritic lesions in calves by the oral inoculation of pure cultures of Clostridium sordellii.Vet. Rec.112 , 141–146 (1983).
  • Richards SM , HuntBW: Clostridium sordellii in lambs.Vet. Rec.111 , 22 (1982).
  • Al-Mashat RR , TaylorDJ: Clostridium sordellii in enteritis in an adult sheep.Vet. Rec.112 , 19 (1983).
  • Popoff MR : Bacteriological examination in enterotoxaemia of sheep and lamb.Vet. Rec.114 , 324 (1984).
  • Bigalke H , ShoerLF: Clostridial neurotoxins. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 407–443 (2000).
  • Herreros J , LalliG, MontecuccoC, SchiavoG: Pathophysiological properties of clostridial neurotoxins. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Freer JH (Eds). Academic Press, London, UK, 202–228 (1999).
  • Humeau Y , DoussauF, GrantNJ, PoulainB: How botulinum and tetanus neurotoxins block neurotransmitter.Biochimie82 , 427–446 (2000).
  • Meunier FA , HerrerosJ, SchiavoG, PoulainB, MolgoJ: Molecular mechanism of action of botulinal neurotoxins and the synaptic remodeling they induce in vivo at the skeletal neuromuscular junction. In: Handbook of Neurotoxicology. Massaro J (Ed.). Humana Press, NJ, USA, 305–347 (2002).
  • Meunier FA , SchiavoG, MolgoJ: Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular trasnmission.J. Physiol.96 , 105–113 (2002).
  • Poulain B , DousseauF, ColasanteC, DeloyeF, MolgoJ: Cellular and molecular mode of action of botulinum and tetanus neurotoxins.Adv. Organ Biol.2 , 285–313 (1997).
  • Poulain B , PopoffMR, MolgoJ: How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechaism of action.Botulinum J.1 , 14–87 (2008).
  • Schiavo G , MatteoliM, MontecuccoC: Neurotoxins affecting neuroexocytosis.Physiol. Rev.80 , 717–766 (2000).
  • Hill KK , SmithTJ, HelmaCH et al.: Genetic diversity among botulinum neurotoxin-producing clostridial strains.J. Bacteriol.189 , 818–832 (2007).
  • Smith TJ , HillKK, FoleyBT et al.: Analysis of the neurotoxin complex genes in Clostridium botulinum A1–A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids.PLoS ONE2 , e1271 (2007).
  • Smith TJ , LouJ, GerenN et al.: Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.Infect. Immun.73 , 5450–5457 (2005).
  • Arndt ER , JacobsonMJ, AbolaEE et al.: A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1–A4.J. Mol. Biol.362 , 733–742 (2006).
  • Chen Y , KorkealaH, AarnikunnasJ, LindstromM: Sequencing the botulinum neurotoxin gene and related genes in Clostridium botulinum type E strains reveals orfx3 and a novel type E neurotoxin subtype.J. Bacteriol.189 , 8643–8650 (2007).
  • Carter AT , PaulCJ, MasonDR et al.: Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum.BMC Genomics10 , 115 (2009).
  • Popoff MR , MarvaudJC: Structural and genomic features of clostridial neurotoxins. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Freer JH (Eds). Academic Press, London, UK, 174–201 (1999).
  • Hasegawa K , WatanabeT, SuzukiT et al.: A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms.J. Biol. Chem.282 , 24777–24783 (2007).
  • Lietzow MA , GielowET, LeD, ZhangJ, VerhagenMF: Subunit stoichiometry of the Clostridium botulinum type A neurotoxin complex determined using denaturing capillary electrophoresis.Protein J.27 , 420–425 (2008).
  • Call JE , CookePH, MillerAJ: In situ characterization of Clostridium botulinum neurotoxin synthesis and export.J. Appl. Bacteriol.79 , 257–263 (1995).
  • Emsley P , FotinouC, BlackI et al.: The structures of the Hc fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding.J. Biol. Chem.275 , 8889–8894 (2000).
  • Lacy DB , StevensRC: Sequence homology and structural analysis of the clostridial neurotoxins.J. Mol. Biol.291 , 1091–1104 (1999).
  • Lacy DB , TeppW, CohenAC, Das Gupta BR, Stevens RC: Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol.5 , 898–902 (1998).
  • Umland TC , WingertLM, SwaminathanS, FureyWF, SchmidtJJ, SaxM: The structure of the receptor binding fragment Hc of tetanus neurotoxin.Nat. Struct. Biol.4 , 788–792 (1997).
  • Fotinou C , EmsleyP, BlackI et al.: The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin.J. Biol. Chem.276 , 3274–3281 (2001).
  • Breidenbach MA , BrungerAT: 2.3 Å crystal structure of tetanus neurotoxin light chain.Biochemistry44 , 7450–7457 (2005).
  • Fu Z , ChenS, BaldwinMR et al.: Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate.Biochemistry45 , 8903–8911 (2006).
  • Swaminathan S , EswaramoorthyS: Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B.Nat. Struct. Biol.7 , 693–699 (2000).
  • Stenmark P , DupuyJ, ImamuraA, KisoM, StevensRC: Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b – insight into the toxin–neuron interaction.PLoS Pathog.4 , e1000129 (2008).
  • Kumaran D , EswaramoorthyS, FureyW, NavazaJ, SaxM, SwaminathanS: Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation.J. Mol. Biol.386 , 233–245 (2009).
  • Maksymowych AB , SimpsonLL: Binding and transcytosis of botulinum neurotoxin by polarized human carcinoma cells.J. Biol. Chem.273 , 21950–21957 (1998).
  • Maksymowych AB , SimpsonLI: Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells.J. Pharmacol. Exp. Ther.210 , 633–641 (2004).
  • Ahsan CR , HajnoczkyG, MaksymowychAB, SimpsonLL: Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells.J. Pharmacol. Exp. Ther.315 , 1028–1035 (2005).
  • Couesnon A , PereiraY, PopoffMR: Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers.Cell. Microbiol.10 , 375–387 (2008).
  • Matsumura T , JinY, KabumotoY et al.: The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption.Cell. Microbiol.10 , 355–364 (2007).
  • Jin Y , TakegaharaY, SugawaraY, MatsumuraT, FujinagaY: Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins – differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C.Microbiology155 , 35–45 (2009).
  • Wellhöner HH : Clostridial toxins and the central nervous system: studies on in situ tissues. In: Botulinum Neurotoxin and Tetanus Toxin. Simpson LL (Ed.). Academic Press, CA, USA, 231–253 (1989).
  • Manning KA , ErichsenJT, EvingerC: Retrograde transneuronal transport properties of fragment C of tetanus toxin.Neuroscience34 , 251–263 (1990).
  • Rossetto O , SevesoM, CaccinP, SchiavoG, MontecuccoC: Tetanus and botulinum neurotoxins: turning bad guys into good by research.Toxicon39 , 27–41 (2001).
  • Nishiki T , KamataY, NemotoY et al.: Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes.J. Biol. Chem.269 , 10498–10503 (1994).
  • Nishiki T , TokuyamaY, KamataY et al.: The high-affinity of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1B/GD1a.FEBS Lett.378 , 253–257 (1996).
  • Jin R , RummelA, BinzT, BrungerAT: Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.Nature444 , 1092–1095 (2006).
  • Rummel A , KarnathT, HenkeT, BigalkeH, BinzT: Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G.J. Biol. Chem.279 , 30865–30870 (2004).
  • Dong M , RichardsDA, GoodnoughMC, TeppWH, JohnsonEA, ChapmanER: Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells.J. Cell Biol.162 , 1293–1303 (2003).
  • Dong M , YehF, TeppWH et al.: SV2 is the protein receptor for botulinum neurotoxin A.Science312 , 592–596 (2006).
  • Mahrhold S , RummelA, BigalkeH, DavletovB, BinzT: The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves.FEBS Lett.580 , 2011–2014 (2006).
  • Dong M , LiuH, TeppWH, JohnsonEA, JanzR, ChapmanER: Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.Mol. Biol. Cell19 , 5226–5237 (2008).
  • Herreros J , LalliG, MontecuccoC, SchiavoG: Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons.J. Neurosci.74 , 1941–1950 (2000).
  • Herreros J , NgT, SchiavoG: Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons.Mol. Biol. Cell12 , 2947–2960 (2001).
  • Munro P , KojimaH, DupontJL, BossuJL, PoulainB, BoquetP: High sensitivity of mouse neuronal cells to tetanus toxin requires a GPI-anchored protein.Biochem. Biophys. Res. Commun.289 , 623–629 (2001).
  • Rummel A , BadeS, AlvesJ, BigalkeH, BinzT: Two carbohydrate binding sites in the Hcc-domain of tetanus neurotoxin are required for toxicity.J. Mol. Biol.326 , 835–847 (2003).
  • Rummel A , EichnerT, WeilT et al.: Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept.Proc. Natl Acad. Sci. USA104 , 359–364 (2007).
  • Rummel A , MahrholdS, BigalkeH, BinzT: The Hcc-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.Mol. Microbiol.51 , 631–643 (2004).
  • Tsukamoto K , KozaiY, IharaH et al.: Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D.Microb. Pathog.44 , 484–493 (2008).
  • Muraro L , TosattoS, MotterliniL, RossettoO, MontecuccoC: The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane.Biochem. Biophys. Res. Commun.380 , 76–80 (2009).
  • Yowler BC , SchengrundCL: Botulinum neurotoxin A changes conformation upon binding to ganglioside GT1b.Biochemistry43 , 9725–9731 (2004).
  • Chen C , BaldwinMR, BarbieriJT: Molecular basis for tetanus toxin coreceptor interactions.Biochemistry47 , 7179–7186 (2008).
  • Lalli G , BohnertS, DeinhardtK, VerasteguiC, SchiavoG: The journey of tetanus and botulinum neurotoxins in neurons.Trends Microbiol.11 , 431–437 (2003).
  • Lalli G , SchiavoG: Analysis of retrograde transport in motor neurons reveals common endocytic carriers for tetanus toxin and neutrophin receptor p75NTR.J. Cell Biol.156 , 233–239 (2002).
  • Bohnert S , DeinhardtK, SalinasS, SchiavoG: Uptake and transport of clostridium neurotoxins. In: The Sourcebook of Comprehensive Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier Academic Press, Amsterdam, The Netherlands, 390–408 (2006).
  • Bohnert S , SchiavoG: Tetanus toxin is transported in a novel neuronal compartment characterized by a specialized pH regulation. 280(51) , 42336–42344 (2005).
  • Deinhardt K , BerminghausenO, WillisonHJ, HopkinsCR, SchiavoG: Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1.J. Cell Biol.174 , 459–471 (2006).
  • Deinhardt K , SalinasS, VerasteguiC et al.: Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway.Neuron52 , 293–305 (2006).
  • Li Y , ForanP, LawrenceG et al.: Recombinant forms of tetanus toxin engineered for examining and exploiting neuronal trafficking pathways.J. Biol. Chem.276 , 31394–31401 (2001).
  • Maskos U , KissaK, St Cloment C, Brulet P: Retrograde trans-synaptic transfer of green fluorescent protein allows the genetic mapping of neuronal circuits in transgenic mice. Proc. Natl Acad. Sci. USA99 , 10120–10125 (2002).
  • Galloux M , VitracH, MontagnerC et al.: Membrane interaction of botulinum neurotoxin A translocation (T) domain. The belt region is a regulatory loop for membrane interaction.J. Biol. Chem.283 , 27668–27676 (2008).
  • Koriazova LK , MontalM: Translocation of botulinum neurotoxin light chain protease through the heavy chain channel.Nat. Struct. Biol.10 , 13–18 (2003).
  • Fischer A , MontalM: Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes.J. Biol. Chem.282 , 29604–29611 (2007).
  • Montal M : Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel.Toxicon54(5) , 565–569 (2008).
  • Ratts R , TrujilloC, BhartiA, van der Spek J, Harrison R, Murphy JR: A conserved motif in transmembrane helix 1 of diphtheria toxin mediates catalytic domain delivery to the cytosol. Proc. Natl Acad. Sci. USA102 , 15635–15640 (2005).
  • Bhalla A , ChickaMC, TuckerWC, ChapmanER: Ca(2+)-synaptotagmin directly regulates t-SNARE function during reconstituted membrane fusion.Nat. Struct. Mol. Biol.13 , 323–330 (2006).
  • Tucker WC , WeberT, ChapmanER: Reconstitution of Ca2+-regulated membrane fusion by synaptotagmin and SNAREs.Science304 , 435–438 (2004).
  • Sakaba T , SteinA, JahnR, NeherE: Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage.Science309 , 491–494 (2005).
  • Lynch KL , GeronaRR, KielarDM, MartensS, McMahonHT, MartinTF: Synaptotagmin-1 utilizes membrane bending and SNARE binding to drive fusion pore expansion.Mol. Biol. Cell19 , 5093–5103 (2008).
  • Gerona RR , LarsenEC, KowalchykJA, MartinTF: The C terminus of SNAP25 is essential for Ca(2+)-dependent binding of synaptotagmin to SNARE complexes.J. Biol. Chem.275 , 6328–6336 (2000).
  • Poulain B , StilesBG, PopoffMR, MolgoJ: Attack of the nervous system by clostridial toxins: physical findings, cellular and molecular actions. In: The Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 348–389 (2006).
  • Foran PG , MohammedN, LiskGO et al.: Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, and E F compared with the long lasting type A.J. Biol. Chem.278 , 1363–1371 (2003).
  • O‘Sullivan GA , MohammedN, ForanPG, LawrenceGW, DollyJO: Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25.J. Biol. Chem.274 , 36897–36904 (1999).
  • Keller JE , NealeEA, OylerG, AdlerM: Persistence of botulinum neurotoxin action in cultured spinal cord cells.FEBS Lett.456 , 137–142 (1999).
  • Fernandez-Salas E , StewardLE, HoH et al.: Plasma membrane localization signals in the light chain of botulinum neurotoxin.Proc. Natl Acad. Sci. USA101 , 3208–3213 (2004).
  • Bajohrs M , RickmanC, BinzT, DavletovB: A molecular basis underlying differences in the toxicity of botulinum serotypes A and E.EMBO Rep.5 , 1090–1095 (2004).
  • Jankovic J : Botulinum toxin in clinical practice.J. Neurol. Neurosurg. Psychiatr.75 , 951–957 (2004).
  • Bihidayasiri R , TruongDD: Expanding use of botulinum toxin.J. Neurol. Sci.235 , 1–9 (2005).
  • Smith CP , SomogyiGT, BooneTB: Botulinum toxin in urology: evaluation using an evidence-based medicine approach.Nat. Clin. Pract. Urol.1 , 31–37 (2004).
  • Juzans P , ComellaJX, MolgoJ, FailleL, Angaut-PetitD: Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle.Neuromusc. Disord.6 , 177–185 (1996).
  • de Paiva A , MeunierF, MolgoJ, AokiKR, DollyJO: Functional repair of motor endpates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.Proc. Natl Acad. Sci. USA96 , 3200–3205 (1999).
  • Meunier FA , LiskG, SesardicD, DollyJO: Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation.Mol. Cell. Neurosci.22 , 454–466 (2003).
  • Morbiato L , CarliL, JohnsonEA, MontecuccoC, MolgoJ, RossettoO: Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.Eur. J. Neurosci.25 , 2697–2704 (2007).
  • Stevens DL , TitballRW, JepsonM, BayerCR, Hayes-SchroerSM, BryantAE: Immunization with the C-domain of α-toxin prevents lethal infection, localizes tissue injury, and promotes host response to challenge with Clostridium perfringens.J. Infect. Dis.190 , 767–773 (2004).
  • Baldwin MR , TeppWH, PrzedpelskiA et al.: Subunit vaccine against the seven serotypes of botulism.Infect. Immun.76 , 1314–1318 (2008).
  • Tavallaie M , ChenalA, GilletD et al.: Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies.FEBS Lett.572 , 299–306 (2004).
  • Aktories K : Toxins as tools. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 976–990 (2006).
  • Perier A , ChenalA, BabonA, MénezA, GilletD: Engineering of bacterial toxins for research and medicine. In: The Comprehensive Source Book of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 991–1007 (2006).
  • Figueiredo DM , HallewellRA, ChenLL et al.: Delivery of recombinant tetanus-superoxide dismutase proteins to central nervous sytem neurons by retrograde axonal transport.Exp. Neurol.145 , 546–554 (1997).
  • Kominsky SL , ValiM, KorzD et al.: Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.Am. J. Pathol.164 , 1627–1633 (2004).
  • Michl P , BuchholzM, RolkeM et al.: Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.Gastroenterology121 , 678–684 (2001).
  • Jolivet-Reynaud C , EstradaJ, WestLA, AloufJE, ChedidL: Targeting of GM2-bearing tumor cells with the cytolytic Clostridium perfringens δ toxin.Anti Cancer Drugs4 , 65–75 (1993).
  • Hirschberg H , ZhangMJ, GachHM et al.: Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens ε prototoxin.J. Neurooncol. (2009) (Epub ahead of print).
  • Anne C , TurcaudS, BlommaertAG, DarchenF, JohnsonEA, RoquesBP: Partial protection against botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity.Chembiochem6 , 1375–1380 (2005).
  • Sukonpan C , OostT, GoodnoughM, TeppW, JohnsonEA, RichDH: Synthesis of substrates and inhibitors of botulinum neurotoxin type A metalloprotease.J. Pept. Res.63 , 181–193 (2004).
  • Couesnon A , ShimizuT, PopoffMR: Differential entry of botulinum neurotoxin A into neuronal and intestinal cells.Cell. Microbiol.11 , 289–308 (2009).
  • Titball RW , BasakAK: Membrane-damaging and cytotoxic phospholipases. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 516–534 (2006).
  • Brynestad S , GranumPE: Clostridium perfringens and foodborne infections.Int. J. Food Microbiol.74 , 195–202 (2002).
  • Smedley JG 3rd, Fisher DJ, Sayeed S, Chakrabarti G, McClane BA: The enteric toxins of Clostridium perfringens.Rev. Physiol. Biochem. Pharmacol.152 , 183–204 (2004).
  • Jestin A , PopoffMR, MaheS: Epizootiologic investigations of a diarrheic syndrom in fattening pigs.Am. J. Vet. Res.10 , 2149–2151 (1985).
  • Miwa N , NishinaT, KuboS, AtsumiM: Most probable number method combined with nested polymerase chain reaction for detection and enumeration of enterotoxigenic Clostridium perfringens in intestinal contents of cattle, pig and chicken.J. Vet. Med. Sci.59 , 89–92 (1997).
  • Collins JE , BergelandME, BouleyD, DucommunAL, FrancisDH, YeskeP: Diarrhea associated with Clostridium perfringens type A enterotoxin in neonatal pigs.J. Vet. Diagn. Invest.1 , 351–353 (1989).
  • Lindsay JA , MachAS, WilkinsonMA et al.: Clostridium perfringens type A cytotoxic-enterotoxin(s) as triggers for death in the sudden infant death syndrome: development of a toxico-infection hypothesis.Curr. Microbiol.27 , 51–59 (1993).
  • Lawrence G : The pathogenesis of pig-bel in Papua New Guinea. 1979.PNG Med. J.48 , 39–49 (2005).
  • Hatheway CL : Toxigenic clostridia.Clin. Microbiol. Rev.3 , 66–98 (1990).
  • Uzal FA , KellyWR: Enterotoxaemia in goats.Vet. Res. Commun.20 , 481–492 (1996).
  • Scholes SF , Welchman Dde B, Hutchinson JP, Edwards GT, Mitchell ES: Clostridium perfringens type D enterotoxaemia in neonatal lambs. Vet. Rec.160 , 811–812 (2007).
  • Rings DM : Clostridial disease associated with neurologic signs: tetanus, botulism, and enterotoxemia.Vet. Clin. North Am. Food Anim. Pract.20 , 379–391, vii–viii (2004).
  • Songer JG , MiskimminsDW: Clostridium perfringens type E enteritis in calves: two cases and a brief review of the literature.Anaerobe10 , 239–242 (2004).
  • Baskerville M , WoodM, SeamerJH: Clostridium perfringens type E enterotoxaemia in rabbits.Vet. Rec.107 , 18–19 (1980).
  • Kuijper E , de Weendt J, Kato H et al.: Nosocomial outbreak of Clostridium difficile-associated diarrhea due to a clindamycin-resistant enterotoxin A-negative strain. Eur. J. Clin. Microbiol. Infect. Dis.20 , 528–534 (2001).
  • Songer JG , AndersonMA: Clostridium difficile: an important pathogen of food animals.Anaerobe12 , 1–4 (2006).
  • Valiquette L , LowDE, PepinJ, McGeerA: Clostridium difficile infection in hospitals: a brewing storm.CMAJ171 , 27–29 (2004).
  • Weese JS , ToxopeusL, ArroyoL: Clostridium difficile associated diarrhoea in horses within the community: predictors, clinical presentation and outcome.Equine Vet. J.38 , 185–188 (2006).
  • Oldfield EC 3rd: Clostridium difficile-associated diarrhea: resurgence with a vengeance. Rev. Gastroenterol. Disord.6 , 79–96 (2006).
  • Goorhuis A , BakkerD, CorverJ et al.: Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.Clin. Infect. Dis.47 , 1162–1170 (2008).
  • Songer JG , UzalFA: Clostridial enteric infections in pigs.J. Vet. Diagn. Invest.17 , 528–536 (2005).
  • Hookman P , BarkinJS: Clostridium difficile associated infection, diarrhea and colitis.World J. Gastroenterol.15 , 1554–1580 (2009).
  • McFarland LV : Antibiotic-associated diarrhea: epidemiology, trends and treatment.Future Microbiol.3 , 563–578 (2008).
  • Kuijper EJ , CoignardB, TullP: Emergence of Clostridium difficile-associated disease in North America and Europe.Clin. Microbiol. Infect.12(Suppl. 6) , 2–18 (2006).
  • Chew SS , LubowskiDZ: Clostridium septicum and malignancy.ANZ J. Surg.71 , 647–649 (2001).
  • Kornbluth AA , DanzigJB, BernsteinLH: Clostridium septicum infection and associated malignancy report of two cases and review of the literature.Medicine (Baltimore)68 , 30–37 (1989).
  • Schamber GJ , BergIE, MolesworthJR: Braxy or bradsot-like abomastitis caused by Clostridium septicum in a calf.Can. Vet. J.27 , 194 (1986).
  • Borriello SP : Clostridial disease of the gut.Clin. Infect. Dis.20(Suppl. 2) , S242–S250 (1995).
  • Borriello SP , CarmanRJ: Association of ι-like toxin and Clostridium spiroforme with both spontaneous and antibiotic-associated diarrhea and colitis in rabbits.J. Clin. Microbiol.17 , 414–418 (1983).
  • Domingo RM , HallerJS, GruenthalM: Infant botulism: two recent cases and literature review.J. Child Neurol.23 , 1336–1346 (2008).
  • Fu SW , WangCH: An overview of type E botulism in China.Biomed. Environ. Sci.21 , 353–356 (2008).
  • Brook I : Infant botulism.J. Perinatol.27 , 175–180 (2007).
  • Sobel J : Botulism.Clin. Infect. Dis.41 , 1167–1173 (2005).
  • McLauchlin J , GrantKA, LittleCL: Food-borne botulism in the United Kingdom.J. Public Health (Oxf.)28 , 337–342 (2006).
  • Aureli P , GiovannaF, PourshabanM: Foodborne botulism in Italy.Lancet348 , 1594 (1996).
  • Eklund MW , DowellJ: Avian Botulism. Charles C Thomas, Springfield, IL, USA (1987).
  • Smart JL : Type C botulism in intensively farmed turkeys.Vet. Rec.113 , 198–200 (1983).
  • Smart JL , RobertsTA: An outbreak of type C botulism in broiler chickens.Vet. Rec.100 , 378–380 (1977).
  • Degernes LA : Waterfowl toxicology: a review.Vet. Clin. North Am. Exot. Anim. Pract.11 , 283–300, vi (2008).
  • Gerber V , StraubR, FreyJ: Equine botulism and acute pasture myodystrophy: new soil-borne emerging diseases in Switzerland?.Schweiz. Arch. Tierheilkd.148 , 553–559 (2006).
  • Galey FD : Botulism in the horse.Vet. Clin. North Am. Equine Pract.17 , 579–588 (2001).
  • Wobeser G : Avian botulism – another perspective.J. Wildl. Dis.33 , 181–186 (1997).
  • Whitlock RH , BuckleyC: Botulism.Vet. Clin. North Am. Equine Pract.13 , 107–128 (1997).
  • Bongers JH , TetenburgGJ: Botulism in waterfowl.Vet. Q.18(Suppl. 3) , S156–S157 (1996).
  • Bergert H , IllertT, FriedrichK, OckertD: Fulminant liver failure following infection by Clostridium perfringens.Surg. Infect. (Larchmt)5 , 205–209 (2004).
  • Temple AM , ThomasNJ: Gas gangrene secondary to Clostridium perfringens in pediatric oncology patients.Pediatr. Emerg. Care20 , 457–459 (2004).
  • Halpin TF , MolinariJA: Diagnosis and management of clostridium perfringens sepsis and uterine gas gangrene.Obstet. Gynecol. Surv.57 , 53–57 (2002).
  • Present DA , MeislinR, ShafferB: Gas gangrene. A review.Orthop. Rev.19 , 333–341 (1990).
  • Rood JI : Virulence genes of Clostridium perfringens.Annu. Rev. Microbiol.52 , 333–360 (1998).
  • O‘Rourke F , SharrockK, PellyM: Clostridium septicum: a malignant pathogen.J. Infect.41 , 286–288 (2000).
  • Smith-Slatas CL , BourqueM, SalazarJC: Clostridium septicum infections in children: a case report and review of the literature.Pediatrics117 , e796–e805 (2006).
  • Barnham M , WeightmanN: Clostridium septicum infection and hemolytic uremic syndrome.Emerg. Infect. Dis.4 , 321–324 (1998).
  • Dirks C , HornH, ChristensenL, PedersenC: CNS infection with Clostridium septicum.Scand. J. Infect. Dis.32 , 320–322 (2000).
  • Stevens DL , MusherDM, WatsonDA et al.: Spontaneous, nontraumatic gangrene due to Clostridium septicum.Rev. Infect. Dis.12 , 286–296 (1990).
  • Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol – United States and Canada, 2001–2005. MMWR Morb. Mortal. Wkly Rep.54 , 724(2005).
  • Miech RP : Pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii.Ann. Pharmacother.39 , 1483–1488 (2005).
  • Wiebe E , GuilbertE, JacotF, ShannonC, WinikoffB: A fatal case of Clostridium sordellii septic shock syndrome associated with medical abortion.Obstet. Gynecol.104 , 1142–1144 (2004).
  • Kimura AC , HigaJI, LevinRM, SimpsonG, VargasY, VugiaDJ: Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users.Clin. Infect. Dis.38 , e87–e91 (2004).
  • Sinave C , Le Templier G, Blouin D, Leveille F, Deland E: Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease. Clin. Infect. Dis.35 , 1441–1443 (2002).
  • Rorbye C , PetersenIS, NilasL: Postpartum Clostridium sordellii infection associated with fatal toxic shock syndrome.Acta Obstet. Gynecol. Scand.79 , 1134–1135 (2000).
  • Abdulla A , YeeL: The clinical spectrum of Clostridium sordellii bacteraemia: two case reports and a review of the literature.J. Clin. Pathol.53 , 709–712 (2000).
  • Bitti A , MastrantonioP, SpigagliaP et al.: A fatal postpartum Clostridium sordellii associated toxic shock syndrome.J. Clin. Pathol.50 , 259–260 (1997).
  • Cunniffe JG : Clostridium sordellii bacteraemia.J. Infect.33 , 127–129 (1996).
  • Spera RV Jr, Kaplan MH, Allen SL: Clostridium sordellii bacteremia: case report and review. Clin. Infect. Dis.15 , 950–954 (1992).
  • Buchman AL , PonsilloM, NagamiPH: Empyema caused by Clostridium sordellii, a rare form of pleuropulmonary disease.J. Infect.22 , 171–174 (1991).
  • McGregor JA , SoperDE, LovellG, ToddJK: Maternal deaths associated with Clostridium sordellii infection.Am. J. Obstet. Gynecol.161 , 987–995 (1989).
  • Fischer M , BhatnagarJ, GuarnerJ et al.: Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion.N. Engl. J. Med.353 , 2352–2360 (2005).
  • Rushdy AA , WhiteJM, RamsayME: Tetanus in England and Wales, 1984–2000.Epidemiol. Infect.130 , 71–77 (2003).
  • Simonsen O , BlochAV, HeronI: Epidemiology of tetanus in Denmark 1920–1982.Scand. J. Infect. Dis.19 , 437–444 (1987).
  • Christenson B , BöttigerM: Epidemiology and immunity to tetanus in Sweden.Scand. J. Infect. Dis.19 , 429–435 (1987).
  • Izurieta H , SutterRW, StrebelPM et al.: Tetanus surveillance – United States, 1991–1994.MMWR Morb. Mortal. Wkly Rep.46 , 15–25 (1997).
  • Tetanus among injecting-drug users – California, 1997. Morb. Mortal. Wkly Rep.47 , 149–151 (1998).
  • Vandelaer J , BirminighamM, GasseF, KurianM, ShawC, GarnierS: Tetanus in developing countries: an update on the maternal and neonatal tetanus elimination initiative.Vaccine21 , 3442–3445 (2003).
  • Gibson K , Bonaventure Uwineza J, Kiviri W, Parlow J: Tetanus in developing countries: a case series and review. Can. J. Anaesth.56 , 307–315 (2009).
  • Merson MH , DowellRR: Epidemiologic, clinical, and laboratory aspects of wound botulism.N. Engl. J. Med.289 , 1005–1010 (1973).
  • Brett MM , HallasG, MpamugoO: Wound botulism in the UK and Ireland.J. Med. Microbiol.53 , 555–561 (2004).
  • Werner SB , PassaroD, McGeeJ, SchechterR, VugiaDJ: Wound botulism in California, 1951–1998: recent epidemic in heroin injectors.Clin. Infect. Dis.31 , 1018–1024 (2000).
  • Akbulut D , DennisJ, GentM et al.: Wound botulism in injectors of drugs: upsurge in cases in England during 2004.Euro Surveill.10 , 172–174 (2005).
  • Kalka-Moll WM , AurbachU, SchaumannR, SchwarzR, SeifertH: Wound botulism in injection drug users.Emerg. Infect. Dis.13 , 942–943 (2007).
  • Burnens A : Cases of wound botulism in Switzerland.Euro Surveill.4 , n5 (2000).
  • Alouf JE , GeoffroyC: The family of the antigenically-related cholesterol-binding (‘sulphydryl-activated‘) cytolytic toxins. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Freer JH (Eds). Academic Press, London, UK, 147–186 (1991).
  • Alouf JE : Cholesterol-binding cytolytic protein toxins.Int. J. Med. Microbiol.290 , 351–356 (2000).
  • Basak A , PopoffMR, TitballRW, ColeAR: Clostridium perfringens ε-toxin. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 631–642 (2006).
  • McClane BA : Clostridium perfringens enterotoxin. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands, 763–778 (2006).
  • Titball RW , RoodJI: Bacterial phospholipases. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 529–556 (2000).
  • Chaves-Olarte E , LowP, FreerP et al.: A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial toxins.J. Biol. Chem.274 , 11046–11052 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.